Dermatomyositis

Response to: ‘Semi-quantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance?’ by Cavazzana et al
Johan Rönnelid, Fabricio Espinosa-Ortega, Ingrid E Lundberg

Annals of the Rheumatic Diseases Jul 2019, annrheumdis-2019-215967; DOI: 10.1136/annrheumdis-2019-215967
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance?
Ilaria Cavazzana, Micaela Fredi, Franco Franceschini

Annals of the Rheumatic Diseases Jul 2019, annrheumdis-2019-215884; DOI: 10.1136/annrheumdis-2019-215884
On using machine learning algorithms to define clinically meaningful patient subgroups
Rachel Knevel, Tom WJ Huizinga

Annals of the Rheumatic Diseases Jul 2019, annrheumdis-2019-215959; DOI: 10.1136/annrheumdis-2019-215959
Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes
Lionel Spielmann, Benoit Nespola, François Séverac, Emmanuel Andres, Romain Kessler, Aurélien Guffroy, Vincent Poindron, Thierry Martin, Bernard Geny, Jean Sibilia, Alain Meyer

Annals of the Rheumatic Diseases Aug 2019, 78 (8) 1101-1106; DOI: 10.1136/annrheumdis-2018-214439
Response to: ‘response to: ‘Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis’ by Sabbagh S et al’ by Yang et al
Sara Sabbagh, Iago Pinal Fernandez, Frederick W Miller, Lisa G Rider, Andrew Lee Mammen

Annals of the Rheumatic Diseases Jun 2019, annrheumdis-2019-215693; DOI: 10.1136/annrheumdis-2019-215693
Response to: ‘Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis’ by Sabbagh et al
Zaixing Yang, Yan Liang

Annals of the Rheumatic Diseases May 2019, annrheumdis-2019-215678; DOI: 10.1136/annrheumdis-2019-215678
Time to personalize the treatment of anti-MDA-5 associated lung disease
Michael Lake, Gautam George, Ross Summer

Annals of the Rheumatic Diseases Jun 2019, 78 (6) e52; DOI: 10.1136/annrheumdis-2018-213285
Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathies
Fabricio Espinosa-Ortega, Marie Holmqvist, Helene Alexanderson, Helena Storfors, Tsuneyo Mimori, Ingrid E Lundberg, Johan Rönnelid

Annals of the Rheumatic Diseases Jun 2019, 78 (6) 858-860; DOI: 10.1136/annrheumdis-2018-214690
Response to: ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’ by Greco et al
Johannes Knitza, Lorenzo Cavagna, Georg Schett, Jörg H W Distler

Annals of the Rheumatic Diseases Apr 2019, annrheumdis-2019-215484; DOI: 10.1136/annrheumdis-2019-215484
Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria
Martin Greco, María Jesus García de Yébenes, Inmaculada Alarcón, Anahy María Brandy-García, Íñigo Rúa-Figueroa, Estibaliz Loza, Loreto Carmona

Annals of the Rheumatic Diseases Mar 2019, annrheumdis-2019-215031; DOI: 10.1136/annrheumdis-2019-215031

Main menu

Dermatomyositis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Dermatomyositis

Pages